![]() |
Volumn 24, Issue 1, 2002, Pages 59-66
|
Regulatory issues for clinical trials in humans
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEW DRUG;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DRUG INDUCED DISEASE;
DRUG RESEARCH;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
HUMAN;
HUMAN RIGHTS;
INFORMED CONSENT;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
TRAINING;
UNITED STATES;
CONTROLLED CLINICAL TRIAL;
FINANCIAL MANAGEMENT;
HEALTH CARE QUALITY;
LEGAL ASPECT;
RANDOMIZED CONTROLLED TRIAL;
HUMAN;
INFORMED CONSENT;
QUALITY ASSURANCE, HEALTH CARE;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH SUPPORT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
HUMANS;
|
EID: 0036019116
PISSN: 0193936X
EISSN: None
Source Type: Journal
DOI: 10.1093/epirev/24.1.59 Document Type: Review |
Times cited : (5)
|
References (28)
|